Group 1 ILCs: Heterogeneity, plasticity, and transcriptional regulation
- PMID: 38563448
- PMCID: PMC11102297
- DOI: 10.1111/imr.13327
Group 1 ILCs: Heterogeneity, plasticity, and transcriptional regulation
Abstract
Group 1 innate lymphoid cells (ILCs), comprising ILC1s and natural killer cells (NK cells), belong to a large family of developmentally related innate lymphoid cells that lack rearranged antigen-specific receptors. NK cells and ILC1s both require the transcription factor T-bet for lineage commitment but additionally rely on Eomes and Hobit, respectively, for their development and effector maturation programs. Both ILC1s and NK cells are essential for rapid responses against infections and mediate cancer immunity through production of effector cytokines and cytotoxicity mediators. ILC1s are enriched in tissues and hence generally considered tissue resident cells whereas NK cells are often considered circulatory. Despite being deemed different cell types, ILC1s and NK cells share many common features both phenotypically and functionally. Recent studies employing single cell RNA sequencing (scRNA-seq) technology have exposed previously unappreciated heterogeneity in group 1 ILCs and further broaden our understanding of these cells. Findings from these studies imply that ILC1s in different tissues and organs share a common signature but exhibit some unique characteristics, possibly stemming from tissue imprinting. Also, data from recent fate mapping studies employing Hobit, RORγt, and polychromic reporter mice have greatly advanced our understanding of the developmental and effector maturation programs of these cells. In this review, we aim to outline the fundamental traits of mouse group 1 ILCs and explore recent discoveries related to their developmental programs, phenotypic heterogeneity, plasticity, and transcriptional regulation.
Keywords: ILC development; ILC1s; NK cells; heterogeneity; innate lymphoid cells; plasticity; transcription factors.
© 2024 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Conflict of interest statement
Conflict of Interest Statement
All authors declare no potential conflicts of interest with respect to publication of this review article.
Figures


Similar articles
-
True Detective: Unraveling Group 1 Innate Lymphocyte Heterogeneity.Trends Immunol. 2019 Oct;40(10):909-921. doi: 10.1016/j.it.2019.08.005. Epub 2019 Sep 6. Trends Immunol. 2019. PMID: 31500958 Free PMC article. Review.
-
Differential phenotypic and functional properties of liver-resident NK cells and mucosal ILC1s.J Autoimmun. 2016 Feb;67:29-35. doi: 10.1016/j.jaut.2015.09.004. Epub 2015 Sep 28. J Autoimmun. 2016. PMID: 26422992
-
Heterogeneity of NK Cells and Other Innate Lymphoid Cells in Human and Murine Decidua.Front Immunol. 2019 Feb 8;10:170. doi: 10.3389/fimmu.2019.00170. eCollection 2019. Front Immunol. 2019. PMID: 30800126 Free PMC article. Review.
-
Diversity and function of group 1 innate lymphoid cells.Immunol Lett. 2016 Nov;179:19-24. doi: 10.1016/j.imlet.2016.07.005. Epub 2016 Jul 6. Immunol Lett. 2016. PMID: 27394699 Free PMC article. Review.
-
Diversity of group 1 innate lymphoid cells in human tissues.Nat Immunol. 2024 Aug;25(8):1460-1473. doi: 10.1038/s41590-024-01885-y. Epub 2024 Jul 2. Nat Immunol. 2024. PMID: 38956380
Cited by
-
Elusive early NK cell progenitor identified.Nat Immunol. 2024 Jul;25(7):1126-1128. doi: 10.1038/s41590-024-01871-4. Nat Immunol. 2024. PMID: 38871998 No abstract available.
-
Circulating innate lymphoid cells are dysregulated in patients with prostate cancer.Cell Mol Biol Lett. 2025 Apr 18;30(1):48. doi: 10.1186/s11658-025-00725-7. Cell Mol Biol Lett. 2025. PMID: 40247153 Free PMC article.
-
Innate Lymphoid Cells.Adv Exp Med Biol. 2025;1476:31-46. doi: 10.1007/978-3-031-85340-1_2. Adv Exp Med Biol. 2025. PMID: 40622538 Review.
-
Decoding innate lymphoid cells and innate-like lymphocytes in asthma: pathways to mechanisms and therapies.J Biomed Sci. 2025 May 12;32(1):48. doi: 10.1186/s12929-025-01142-w. J Biomed Sci. 2025. PMID: 40355861 Free PMC article. Review.
-
Microbiota metabolite taurodeoxycholic acid maintains intestinal tissue residency of innate lymphoid cells via engagement with P2Y10 receptor.Sci Adv. 2025 Aug 22;11(34):eadt9645. doi: 10.1126/sciadv.adt9645. Epub 2025 Aug 22. Sci Adv. 2025. PMID: 40845099 Free PMC article.
References
-
- Klose CS, Artis D. Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis. Nat Immunol. 2016;17(7):765–774. - PubMed
-
- Meininger I, Carrasco A, Rao A, Soini T, Kokkinou E, Mjosberg J. Tissue-Specific Features of Innate Lymphoid Cells. Trends Immunol. 2020;41(10):902–917. - PubMed
-
- Cherrier DE, Serafini N, Di Santo JP. Innate Lymphoid Cell Development: A T Cell Perspective. Immunity. 2018;48(6):1091–1103. - PubMed
-
- Vivier E, Artis D, Colonna M, et al. Innate Lymphoid Cells: 10 Years On. Cell. 2018;174(5):1054–1066. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources